Cervical Cancer: What Should We Tell Women About Screening?
- 1 August 2006
- journal article
- review article
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 10 (4) , 527-31
Abstract
Cervical cancer is the second most common cancer among women worldwide, with significantly higher rates in developing areas, especially in Africa, the Caribbean, and Latin America (Parkin, Bray, Ferlay, & Pisani, 2005). In contrast, incidence and mortality rates of cervical cancer in the United States have declined significantly among women of all ethnic and racial groups; it is not among the top 10 leading causes of new cancer cases in women (American Cancer Society [ACS], 2006b; Edwards et al.,2005).Keywords
This publication has 21 references indexed in Scilit:
- Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2005
- Screening for Cervical Cancer and Initial Treatment of Patients With Abnormal Results From Papanicolaou TestingMayo Clinic Proceedings, 2005
- The Role of Self-Collection Devices for Cytology and Human Papillomavirus DNA Testing in Cervical Cancer ScreeningClinical Obstetrics and Gynecology, 2005
- Current Techniques for the Evaluation of Abnormal Cervical CytologyClinical Obstetrics and Gynecology, 2005
- Interventions That Address Cancer Health Disparities in WomenFamily & Community Health, 2005
- Social and Cultural Barriers to Papanicolaou Test Screening in an Urban PopulationObstetrics & Gynecology, 2004
- Evidence for Practice: Oral Contraception and Risk of Cervical CancerJournal of the American Academy of Nurse Practitioners, 2004
- The Epidemiology of Cervical CancerThe Cancer Journal, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Epidemiology of Genital Human Papillomavirus InfectionThe American Journal of Medicine, 1997